EcoDrugPlus

Bradykinin Receptor B1

Ensembl ID : ENSMOCG00000003519
Gene Symbol: BDKRB1
3 Cross references
147 Possible Orthologues:

Bradykinin Receptor B2

Ensembl ID : ENSMOCG00000003607
Gene Symbol: BDKRB2
3 Cross references
356 Possible Orthologues:

Butyrylcholinesterase

Ensembl ID : ENSMOCG00000002708
Gene Symbol: BCHE
3 Cross references
130 Possible Orthologues:

Calcitonin Receptor Like Receptor

Ensembl ID : ENSMOCG00000019683
Gene Symbol: CALCRL
3 Cross references
147 Possible Orthologues:

Calcium Channel, Voltage-Dependent, P/q Type, Alpha 1a Subunit

Ensembl ID : ENSMOCG00000014432
Gene Symbol: CACNA1A
1 Cross references
284 Possible Orthologues:

Calcium Channel, Voltage-Dependent, Alpha 1f Subunit

Ensembl ID : ENSMOCG00000003974
Gene Symbol: CACNA1F
1 Cross references
178 Possible Orthologues:

Calcium Channel, Voltage-Dependent, Gamma Subunit 6

Ensembl ID : ENSMOCG00000008928
Gene Symbol: CACNG6
1 Cross references
248 Possible Orthologues:

Calcium Channel, Voltage-Dependent, Gamma Subunit 8

Ensembl ID : ENSMOCG00000000496
Gene Symbol: CACNG8
1 Cross references
238 Possible Orthologues:

Calcium Sensing Receptor

Ensembl ID : ENSMOCG00000010550
Gene Symbol: CASR
3 Cross references
202 Possible Orthologues:

Calcium Voltage-Gated Channel Auxiliary Subunit Alpha2delta 1

Ensembl ID : ENSMOCG00000016976
Gene Symbol: CACNA2D1
3 Cross references
285 Possible Orthologues:

Calcium Voltage-Gated Channel Auxiliary Subunit Alpha2delta 2

Ensembl ID : ENSMOCG00000001804
Gene Symbol: CACNA2D2
3 Cross references
272 Possible Orthologues:

Calcium Voltage-Gated Channel Auxiliary Subunit Alpha2delta 3

Ensembl ID : ENSMOCG00000020648
Gene Symbol: CACNA2D3
3 Cross references
309 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).